Callahan Advisors LLC lifted its holdings in Monsanto Company (NYSE:MON) by 9.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 60,023 shares of the basic materials company’s stock after acquiring an additional 5,335 shares during the period. Callahan Advisors LLC’s holdings in Monsanto were worth $7,192,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. Raymond James Financial Services Advisors Inc. increased its position in shares of Monsanto by 1.4% during the third quarter. Raymond James Financial Services Advisors Inc. now owns 42,996 shares of the basic materials company’s stock worth $5,152,000 after acquiring an additional 595 shares during the period. Calamos Advisors LLC grew its holdings in Monsanto by 3.7% in the third quarter. Calamos Advisors LLC now owns 55,304 shares of the basic materials company’s stock worth $6,627,000 after purchasing an additional 1,977 shares during the last quarter. Meyer Handelman Co. grew its holdings in Monsanto by 0.6% in the third quarter. Meyer Handelman Co. now owns 124,552 shares of the basic materials company’s stock worth $14,923,000 after purchasing an additional 706 shares during the last quarter. Carroll Financial Associates Inc. grew its holdings in Monsanto by 13.9% in the third quarter. Carroll Financial Associates Inc. now owns 4,816 shares of the basic materials company’s stock worth $577,000 after purchasing an additional 588 shares during the last quarter. Finally, Aperio Group LLC grew its holdings in Monsanto by 41.0% in the third quarter. Aperio Group LLC now owns 275,071 shares of the basic materials company’s stock worth $32,959,000 after purchasing an additional 79,916 shares during the last quarter. 74.50% of the stock is owned by hedge funds and other institutional investors.
In other news, CFO Pierre Courduroux sold 4,320 shares of the stock in a transaction that occurred on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total value of $527,040.00. Following the completion of the sale, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at $5,903,336. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Brett D. Begemann sold 22,640 shares of the firm’s stock in a transaction on Monday, September 25th. The stock was sold at an average price of $120.03, for a total value of $2,717,479.20. Following the completion of the transaction, the chief operating officer now directly owns 85,439 shares of the company’s stock, valued at $10,255,243.17. The disclosure for this sale can be found here. Insiders sold 49,236 shares of company stock valued at $5,931,934 in the last ninety days. Corporate insiders own 0.79% of the company’s stock.
Several equities research analysts have recently commented on the stock. Barclays PLC reiterated an “equal weight” rating and set a $124.00 price objective (up from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. Royal Bank Of Canada restated a “hold” rating and set a $128.00 target price on shares of Monsanto in a research report on Wednesday, August 2nd. BMO Capital Markets reaffirmed a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a report on Thursday, October 5th. Piper Jaffray Companies set a $128.00 target price on shares of Monsanto and gave the stock a “buy” rating in a research note on Friday, August 11th. Finally, Vetr cut shares of Monsanto from a “buy” rating to a “hold” rating and set a $122.35 target price for the company. in a research note on Wednesday, August 2nd. Eleven research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $124.61.
TRADEMARK VIOLATION NOTICE: This news story was published by Week Herald and is the property of of Week Herald. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://weekherald.com/2017/11/15/monsanto-company-mon-stake-increased-by-callahan-advisors-llc.html.
Shares of Monsanto Company (NYSE MON) opened at $118.05 on Wednesday. Monsanto Company has a twelve month low of $97.65 and a twelve month high of $122.79. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.35 and a quick ratio of 0.83. The stock has a market cap of $52,040.00, a P/E ratio of 21.39, a P/E/G ratio of 1.70 and a beta of 1.05.
Monsanto (NYSE:MON) last issued its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.61. The business had revenue of $2.69 billion during the quarter, compared to analyst estimates of $2.51 billion. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The business’s revenue was up 4.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.07 earnings per share. equities analysts anticipate that Monsanto Company will post 5.74 EPS for the current year.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.